跳至主要内容
临床试验/ISRCTN17706836
ISRCTN17706836
已完成
2 期

Sleep, wake and light therapy for depression: a randomised parallel trial

South London and Maudsley NHS Foundation Trust0 个研究点目标入组 93 人2018年1月22日

概览

阶段
2 期
干预措施
未指定
疾病 / 适应症
nipolar major depression
发起方
South London and Maudsley NHS Foundation Trust
入组人数
93
状态
已完成
最后更新
4年前

概览

简要总结

2021 Results article in https://doi.org/10.1192/bjo.2021.1044 (added 09/12/2021)

注册库
who.int
开始日期
2018年1月22日
结束日期
2019年8月31日
最后更新
4年前
研究类型
Interventional
性别
All

研究者

入排标准

入选标准

  • 1\. Diagnosis of Depressive Episode (ICD10 F32\) or Recurrent Depressive Disorder (F33\)
  • 2\. Minimum score of 8 or more on the Hamilton Depression Rating Scale (6 item) (Range 0\-22\) (Bech,1981\)
  • 3\. Age 18\-65
  • 4\. Able to give informed consent
  • 5\. Women of child bearing age may be included and no methods of contraception is required to enable inclusion into the trial

排除标准

  • 1\. Current diagnosis of Seasonal Affective Disorder
  • 2\. Current diagnosis of anorexia nervosa or bulimia
  • 3\. Current diagnosis of an obsessive compulsive or related disorder
  • 4\. Current diagnosis of post\-traumatic stress disorder
  • 5\. History of schizophrenia, schizoaffective disorder or bipolar disorder
  • 6\. Severe cognitive impairment, dementia, intellectual disability or organic brain disorder
  • 7\. History of stimulant or hallucinogenic misuse, alcohol or substance misuse or dependence in past 3 months
  • 8\. Borderline Personality Disorder or other personality disorder considered to be the main problem
  • 9\. Duration of depression more than 2 years
  • 10\. Significant risk of suicide that requires hospitalisation

结局指标

主要结局

未指定

相似试验